Kinetics of postbiopsy levels of serum free prostate-specific antigen and percent free prostate-specific antigen

Urology

Volumn 53, Issue 4, 1999, Pages 731-735

  Lechevallier, Eric ^a   Eghazarian, Christophe ^b   Ortega, Jean Claude ^b   Daniel, Laurent ^a   Roux, François ^a   Thirion, Xavier ^b   Coulange, Christian ^b  

^a Child and Adolescent Psychopathology Unit Salvator Hospital Public Assistance Marseille Hospitals University Aix Marseille II   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADENOCARCINOMA; ADULT; AGED; ANTIGEN SPECIFICITY; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; GLOMERULUS FILTRATION; HALF LIFE TIME; HUMAN; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY;

ADENOCARCINOMA; AGED; BIOPSY, NEEDLE; HUMANS; KINETICS; MALE; MIDDLE AGED; PROSTATE; PROSTATE-SPECIFIC ANTIGEN;

EID: 0033119884     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(98)00607-4     Document Type: Article

References (13)

1. Stenman UH, Leinonen J, Alfthan H, et al: A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer. Cancer Res 51: 222-226, 1991.
2. Zhang WM, Leinonen J, Kalkkinen N, et al: Prostate-specific antigen forms a complex with and cleaves alpha 1-protease inhibitor in vitro. Prostate 33: 87-96, 1997.
3. Ravery V, Meulemans A, and Boccon-Gibod L: Clearance of free and total serum prostate-specific antigen after prostatic surgery. Eur Urol 33: 251-254, 1998.
4. Partin AW, Piantadosi S, Subong EN, et al: Clearance rate of serum-free and total PSA following radical retropubic prostatectomy. Prostate Suppl 7: 35-39, 1996.
5. Ornstein DK, Rao GS, Smith DH, et al: Effect of digital rectal examination and needle biopsy on serum total and percentage of free prostate-specific antigen levels. J Urol 157: 195-198, 1997.
6. Collins GN, Martin PJ, Wynn-Davis A, et al: The effect of digital rectal examination, flexible cystoscopy and prostatic biopsy on free and total prostate-specific antigen, and the free-to-total PSA ratio in clinical practice. J Urol 157: 1744-1747, 1997.
7. Rodriguez-Rubio EI, Robles JE, Gonzalez A, et al: Effect of digital rectal examination and flexible cystoscopy on free and total prostate-specific antigen, and the percentage of free PSA. Eur Urol 33: 255-260, 1998.
8. Siegel S, and Castellan NJ Jr: Wilcoxon Test in Nonparametric Statistics for the Behavioral Sciences, 2nd ed. New York, McGraw-Hill, 1988, pp 87-95.
9. Woodrum DL, Brawer MK, Partin AW, et al: Interpretation of free prostate-specific antigen clinical research studies for the detection of prostate cancer. J Urol 159: 5-12, 1998.
10. Catalona WJ, Partin AW, Slawin KM, et al: Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial. JAMA 279: 1542-1547, 1998.
11. Ornstein DK, Smith DS, Humphrey PA, et al: The effect of prostate volume, age, total prostate-specific antigen and acute inflamation on the percentage of free serum PSA levels in men without clinically detectable prostate cancer. J Urol 159: 1234-1237, 1998.
12. Björk T, Ljunberg B, Piironen T, et al: Rapid exponential elimination of free prostate-specific antigen contrasts the slow, capacity-limited elimination of PSA complexed to alpha 1-antichymotrypsin from serum. Urology 51: 57-62, 1998.
13. Chen Z, Komatsu K, Prestigiacomo A, et al: Addition of purified prostate specific antigen to serum from female subjects: studies on the relative inhibition by alpha 2-macroglobulin and alpha 1-antichymotrypsin. J Urol 156: 1357-1363, 1996.